A common amino acid may shield kidneys after heart surgery — a massive analysis puts it to the test

NCT ID NCT07718373

First seen Jul 22, 2026 · Last updated Jul 23, 2026 · Updated 1 time

Summary

Acute kidney injury is a frequent and serious complication after cardiac surgery, and effective prevention remains elusive. This study analyzes data from 5,000 adults who had heart surgery with a heart-lung machine to see whether giving the amino acid L-arginine within the first three days after surgery lowers their risk of kidney damage. L-arginine is a building block for nitric oxide, a molecule that helps blood vessels relax and may improve kidney blood flow.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
the amino acid L-arginine given intravenously within the first three days after heart surgery
What this could lead to
If L-arginine proves protective, it could offer a simple, low-cost way to reduce kidney damage after cardiac surgery.
What could go wrong
This is an observational analysis, not a randomized trial, so results may be influenced by other factors. L-arginine can also cause side effects like low blood pressure or electrolyte imbalances.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE KIDNEY INJURY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.